Geode Capital Management LLC Purchases 10,538 Shares of Enhabit, Inc. (NYSE:EHAB)

Geode Capital Management LLC boosted its holdings in shares of Enhabit, Inc. (NYSE:EHAB) by 0.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,137,458 shares of the company’s stock after acquiring an additional 10,538 shares during the period. Geode Capital Management LLC owned about 2.26% of Enhabit worth $8,987,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. WINTON GROUP Ltd purchased a new stake in shares of Enhabit in the 2nd quarter worth approximately $955,000. Marshall Wace LLP purchased a new position in Enhabit during the second quarter valued at approximately $1,941,000. Systematic Financial Management LP raised its stake in Enhabit by 12.2% in the third quarter. Systematic Financial Management LP now owns 1,838,199 shares of the company’s stock worth $14,522,000 after buying an additional 199,235 shares in the last quarter. Dynamic Technology Lab Private Ltd purchased a new stake in Enhabit during the third quarter worth $215,000. Finally, AREX Capital Management LP boosted its position in Enhabit by 2.5% during the 2nd quarter. AREX Capital Management LP now owns 2,472,662 shares of the company’s stock valued at $22,056,000 after acquiring an additional 59,353 shares in the last quarter.

Insider Activity

In other news, Director Jeffrey Bolton purchased 4,000 shares of the stock in a transaction on Thursday, December 12th. The stock was bought at an average price of $8.69 per share, with a total value of $34,760.00. Following the transaction, the director now owns 98,144 shares in the company, valued at $852,871.36. The trade was a 4.25 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Stuart M. Mcguigan acquired 15,000 shares of the business’s stock in a transaction dated Tuesday, December 10th. The stock was purchased at an average cost of $8.81 per share, for a total transaction of $132,150.00. Following the completion of the acquisition, the director now directly owns 46,810 shares of the company’s stock, valued at approximately $412,396.10. This trade represents a 47.15 % increase in their position. The disclosure for this purchase can be found here. Corporate insiders own 1.90% of the company’s stock.

Enhabit Price Performance

NYSE EHAB opened at $7.81 on Thursday. Enhabit, Inc. has a 12-month low of $6.85 and a 12-month high of $11.74. The firm’s fifty day simple moving average is $7.72 and its two-hundred day simple moving average is $8.18. The company has a current ratio of 1.46, a quick ratio of 1.46 and a debt-to-equity ratio of 0.85. The firm has a market capitalization of $392.72 million, a P/E ratio of -3.37 and a beta of 1.89.

Enhabit (NYSE:EHAB) last announced its earnings results on Wednesday, November 6th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by ($0.01). Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. The business had revenue of $253.60 million for the quarter, compared to analyst estimates of $261.69 million. During the same period in the prior year, the company earned $0.03 earnings per share. Analysts forecast that Enhabit, Inc. will post 0.22 EPS for the current fiscal year.

Analyst Ratings Changes

EHAB has been the subject of several recent research reports. Jefferies Financial Group raised Enhabit from a “hold” rating to a “buy” rating and boosted their price target for the stock from $8.25 to $9.50 in a research report on Monday, December 9th. Leerink Partners reiterated a “market perform” rating and issued a $8.00 target price (down previously from $8.50) on shares of Enhabit in a research note on Tuesday, November 19th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the company’s stock. According to data from MarketBeat.com, Enhabit presently has a consensus rating of “Hold” and an average target price of $8.75.

Enhabit Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.